United States · FDA National Drug Code directory
Adenosine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-651_5af5d3b5-1a03-4717-b828-97589f278992
- Product NDC
- 63323-651
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Adenosine
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180416
- Source listing expiry
- 20261231
Source-listed ingredients
- ADENOSINE — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE, PLASTIC in 1 CARTON (63323-651-89) / 2 mL in 1 SYRINGE, PLASTIC (63323-651-21) · 63323-651-89
- 10 SYRINGE, PLASTIC in 1 CARTON (63323-651-90) / 4 mL in 1 SYRINGE, PLASTIC (63323-651-23) · 63323-651-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →